6-56615576-GTTTA-TAC
Variant summary
Our verdict is Uncertain significance. The variant received 5 ACMG points: 5P and 0B. PVS1_ModeratePM2PP5
The NM_001723.7(DST):c.7887_7891delTAAACinsGTA(p.Lys2630TyrfsTer6) variant causes a frameshift, missense change involving the alteration of a non-conserved nucleotide. The variant was absent in control chromosomes in GnomAD project. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars).
Frequency
Consequence
NM_001723.7 frameshift, missense
Scores
Clinical Significance
Conservation
Publications
- hereditary sensory and autonomic neuropathy type 6Inheritance: AR Classification: DEFINITIVE, STRONG, MODERATE, SUPPORTIVE, LIMITED Submitted by: Orphanet, Ambry Genetics, G2P, ClinGen, Labcorp Genetics (formerly Invitae)
- epidermolysis bullosa simplex 3, localized or generalized intermediate, with BP230 deficiencyInheritance: AR Classification: STRONG, MODERATE, SUPPORTIVE Submitted by: PanelApp Australia, Ambry Genetics, Genomics England PanelApp, Labcorp Genetics (formerly Invitae), Orphanet
Genome browser will be placed here
ACMG classification
Our verdict: Uncertain_significance. The variant received 5 ACMG points.
Variant Effect in Transcripts
ACMG analysis was done for transcript: NM_001723.7. You can select a different transcript below to see updated ACMG assignments.
RefSeq Transcripts
| Selected | Gene | Transcript | Tags | HGVSc | HGVSp | Effect | Exon Rank | Protein | UniProt |
|---|---|---|---|---|---|---|---|---|---|
| DST | NM_001723.7 | MANE Plus Clinical | c.7887_7891delTAAACinsGTA | p.Lys2630TyrfsTer6 | frameshift missense | Exon 24 of 24 | NP_001714.1 | ||
| DST | NM_001374736.1 | MANE Select | c.4930-1096_4930-1092delTAAACinsGTA | intron | N/A | NP_001361665.1 | |||
| DST | NM_001374734.1 | c.4957-1096_4957-1092delTAAACinsGTA | intron | N/A | NP_001361663.1 |
Ensembl Transcripts
| Selected | Gene | Transcript | Tags | HGVSc | HGVSp | Effect | Exon Rank | Protein | UniProt |
|---|---|---|---|---|---|---|---|---|---|
| DST | ENST00000370765.11 | TSL:1 MANE Plus Clinical | c.7887_7891delTAAACinsGTA | p.Lys2630TyrfsTer6 | frameshift missense | Exon 24 of 24 | ENSP00000359801.6 | ||
| DST | ENST00000680361.1 | MANE Select | c.4930-1096_4930-1092delTAAACinsGTA | intron | N/A | ENSP00000505098.1 | |||
| DST | ENST00000244364.10 | TSL:1 | c.3319-1096_3319-1092delTAAACinsGTA | intron | N/A | ENSP00000244364.6 |
Frequencies
GnomAD3 genomes Cov.: 32
GnomAD4 genome Cov.: 32
ClinVar
Submissions by phenotype
not provided Pathogenic:1
Has not been previously published as pathogenic or benign to our knowledge; Frameshift variant predicted to result in protein truncation as the last 20 amino acids are replaced with 5 different amino acids, although loss-of-function variants have not been reported downstream of this position in the protein; Not observed at significant frequency in large population cohorts (gnomAD)
Hereditary sensory and autonomic neuropathy type 6;C3809470:Epidermolysis bullosa simplex 3, localized or generalized intermediate, with BP230 deficiency Uncertain:1
This sequence change creates a premature translational stop signal (p.Lys2630Tyrfs*6) in the DST gene. While this is not anticipated to result in nonsense mediated decay, it is expected to disrupt the last 20 amino acid(s) of the DST protein. The frequency data for this variant in the population databases is considered unreliable, as metrics indicate poor data quality at this position in the gnomAD database. This variant has not been reported in the literature in individuals affected with DST-related conditions. Experimental studies and prediction algorithms are not available or were not evaluated, and the functional significance of this variant is currently unknown. In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance.
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at